The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic Syndrome

<table>A proposed mechanism of how metabolic syndrome and NAFLD influence carcinogenesis in colorectal cancer. MS: metabolic syndrome; ILGF-1: insulin-like growth factor-1; IGFBP-3: insulin growth factor binding protein-3; VEGF: vascular endothelial growth factor; TNF: tumour necrosis factor.</table>

Journal of Obesity

fig2

Figure 2

Figure 2: The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic Syndrome 

Figure 2 | The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic Syndrome 